COCO · Vita Coco Company, Inc. · Insider Trading

The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.

The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.

The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.19 to $83.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.40 to $81.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These shares are held by the Ira Liran Revocable Trust

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.40 to $81.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These shares are held by the Ira Liran 2012 Family Trust.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.35 to $80.37, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These shares are held by the Ira Liran 2012 Family Trust.

The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.19 to $80.37, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These shares are held by the Ira Liran Revocable Trust

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

Represents deferred RSUs granted under the Issuers 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

Represents RSUs granted under the Company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided the Reporting Person remains in continuous service on the applicable vesting date. Each RSU represents the right to receive one share of common stock of the Issuer.

Represents RSUs granted under the Company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided the Reporting Person remains in continuous service on the applicable vesting date. Each RSU represents the right to receive one share of common stock of the Issuer.

Represents RSUs granted under the Company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided the Reporting Person remains in continuous service on the applicable vesting date. Each RSU represents the right to receive one share of common stock of the Issuer.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.54 to $78.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

These shares are held by the Michael Kirban Revocable Trust.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.68 to $60.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The stock option is fully vested and currently exercisable.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The stock option is fully vested and currently exercisable.

The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

The stock option is fully vested and currently exercisable.